ReviewJSES reviews, reports, and techniques2026
Postoperative nonsteroidal anti-inflammatory drug prophylaxis for elbow heterotopic ossification: a systematic review and meta-analysis comparing COX-2 selective and nonselective inhibitors.
Review in JSES reviews, reports, and techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heterotopic ossification (HO) is a significant complication following elbow trauma and surgery, leading to pain, stiffness, and functional impairment. While nonsteroidal anti-inflammatory drugs (NSAIDs) have been extensively investigated for HO prophylaxis, their effectiveness in preventing postoperative HO in the elbow remains unclear. This study aims to compare the efficacy of selective vs. nonselective NSAIDs in reducing postoperative HO rates after traumatic elbow surgeries. Methods: This systematic review and meta-analysis were conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A comprehensive search was performed in PubMed, Embase, Cochrane Library, and Web of Science from January 2004 to January 10, 2025. Level I-III studies were included if they examined patients who underwent elbow surgery following trauma and compared selective COX-2 inhibitors or nonselective NSAIDs to no prophylaxis, with reported postoperative HO formation rates. Results: A total of 2,429 articles were identified across the four databases. Following full-text review, 1 randomized control trial and 5 retrospective studies were included in the quantitative synthesis, comprising patients who underwent either acute post-traumatic surgery or postexcision/open arthrolysis for established HO. Both selective (celecoxib) and nonselective (indomethacin) NSAIDs demonstrated no statistically significant difference in reducing postoperative HO compared with controls (celecoxib: risk ratio = 0.64, 95% confidence interval 0.32-1.31, Conclusion: This study demonstrates that both selective (celecoxib) and nonselective (indomethacin and ibuprofen) NSAIDs effectively reduce the risk of HO following elbow trauma surgery. When analyzed individually, neither the selective COX-2 inhibitor (celecoxib) nor the nonselective NSAIDs (indomethacin, ibuprofen) showed a statistically significant difference compared with controls, indicating no clear difference in efficacy between NSAID classes. However, given the limited number of studies and interstudy heterogeneity, the overall power of the current evidence is low, and further prospective research is needed to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.